Esotropia Clinical Trial
Official title:
Early Versus Delayed Surgery for Infantile Esotropia: A Clinical Evaluation of Sensory and Motor Outcomes
NCT number | NCT01166503 |
Other study ID # | 1000005134 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 2004 |
Est. completion date | April 26, 2018 |
Verified date | June 2018 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy).
Status | Completed |
Enrollment | 71 |
Est. completion date | April 26, 2018 |
Est. primary completion date | April 2, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 3 Months to 23 Months |
Eligibility |
Inclusion Criteria: 1. onset of esotropia after 10 weeks of age; 2. constant esotropia = 20° (40 prism diopter or PD) at near (1/3 m) on two examinations, separated by 2-4 weeks; and 3. refractive error = +3.00 diopters (far-sightedness). Exclusion Criteria: 1. gestational age < 34 weeks; 2. birth weight = 1500 g; 3. ventilator treatment in the newborn period; 4. history of meningitis or other major medical event; 5. developmental delay; 6. incomitant or paralytic strabismus; 7. manifest nystagmus or head bobbing; 8. prior eye muscle surgery; 9. prior treatment of amblyopia or spectacle correction for refractive errors; 10. presence of structural ocular anomalies. |
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motion visual evoked potential (mVEPs) asymmetry | mVEP measures the perception of nasalward and temporalward motion for each eye at the cortical level. A nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better for one direction over the other. | at age 2 years | |
Primary | Stereopsis | This measures the level of 3D depth perception. | at 2 and 5 years of age | |
Primary | Optokinetic nystagmus (OKN) asymmetry | OKN is measured in both the nasalward and temporalward directions for each eye. From this a nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better in one direction or the other. | at age 5 years | |
Primary | Global Motion Perception | Motion perception will be tested using two tasks: motion detection (at age 2 and 5 years) and motion discrimination (at age 5 years). | at 2 and 5 years of age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05527015 -
Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near
|
Phase 3 | |
Completed |
NCT00746304 -
Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin
|
N/A | |
Completed |
NCT01460355 -
Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone
|
Phase 4 | |
Recruiting |
NCT06077682 -
Cycloplegic Refraction in Pediatric Patients With Esotropia
|
Phase 4 | |
Completed |
NCT02570555 -
Strabismus Surgery and Driving Ability
|
||
Active, not recruiting |
NCT00993174 -
Surgery for Esotropia Under Topical Anesthesia
|
N/A | |
Completed |
NCT00000121 -
The Prism Adaptation Study (PAS)
|
Phase 3 | |
Active, not recruiting |
NCT02404324 -
Conservative Treatment of Esotropia in Children up to 3 Years Old
|
N/A | |
Completed |
NCT04429659 -
Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia
|
||
Recruiting |
NCT05615519 -
Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
|
||
Completed |
NCT00000163 -
Congenital Esotropia Observational Study (CEOS)
|
N/A | |
Recruiting |
NCT01616108 -
Bupivacaine Injection of Eye Muscles to Treat Strabismus
|
Phase 2/Phase 3 |